The Food and Drug Administration (FDA) has approved a shelf life extension for certain lots of CMP Pharma’s Potassium Phosphates Injection in order to mitigate drug shortage concerns.
CMP Pharma’s Potassium Phosphates Injection is a phosphorus replacement product indicated as a source of phosphorus in adults and pediatric patients 12 years of age and older when oral or enteral replacement is not possible, insufficient or contraindicated. It is also approved for parenteral nutrition in adults weighing at least 45kg and pediatric patients 12 years of age and older weighing at least 40kg when oral or enteral nutrition is not possible, insufficient or contraindicated.
The new extended use dates for CMP Pharma’s Potassium Phosphates Injection (phosphorus 45mmol/15mL [3mmol/mL] and potassium 71mEq/15mL [4.7mEq/mL]) include:
Continue Reading
- NDC Number 46287-024-10 (cartons) and NDC Number 46287-024-15 (individual vials)
- Lot# CR31; Expiration Date (labeled) June 2023; Extended Use Date December 2023
- Lot# CR86; Expiration Date (labeled) June 2023; Extended Use Date December 2023
- Lot# CS86; Expiration Date (labeled) October 2023; Extended Use Date April 2024
- Lot# CS89; Expiration Date (labeled) October 2023; Extended Use Date April 2024
- Lot# CS96; Expiration Date (labeled) October 2023; Extended Use Date April 2024
- Lot# CT36; Expiration Date (labeled) November 2023; Extended Use Date May 2024
- Lot# CT40; Expiration Date (labeled) November 2023; Extended Use Date May 2024
This article originally appeared on MPR
